Manufacturers should demonstrate that any new technology or system not simply meets the present criteria for sterility assurance but additionally provides tangible Advantages concerning performance, trustworthiness, or merchandise safety. As these new technologies arise, the WHO emphasizes the importance of a thorough risk assessment and validation approach. This information Successfully Submitted (Awaiting Approval)